Benzinga | Mar 17, 2021 04:07PM EDT

CTI BioPharma Q4 EPS $(0.20) Misses $(0.16) Estimate

CTI BioPharma (NASDAQ:CTIC) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 42.86 percent decrease over losses of $(0.14) per share from the same period last year.